(S)-N-(1-(4-(5-chloro-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidin-1-yl)propan-2-yl)naphthalene-2-carboxamide (Compound)

Description: A compound in the knowledge graph

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View (S)-N-(1-(4-(5-chloro-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidin-1-yl)propan-2-yl)naphthalene-2-carboxamide's neighborhood in the knowledge graph.

Submit

Knowledge Graph Assertions

Source	Relation	Target	Evidence
(S)-N-(1-(4-(5-chloro-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidin-1-yl)propan-2-yl)naphthalene-2-carboxamide Compound (Entity type)	In similarity relationship with Knowledge Graph Relation (Entity type)	Obatoclax Compound (Entity type)	0.5574653744697571
(S)-N-(1-(4-(5-chloro-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidin-1-yl)propan-2-yl)naphthalene-2-carboxamide Compound (Entity type)	In similarity relationship with Knowledge Graph Relation (Entity type)	Thioridazine Compound (Entity type)	0.5726276636123657
(S)-N-(1-(4-(5-chloro-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidin-1-yl)propan-2-yl)naphthalene-2-carboxamide Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	CLTB Gene (Entity type)	-0.0049986923
(S)-N-(1-(4-(5-chloro-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidin-1-yl)propan-2-yl)naphthalene-2-carboxamide Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	ELOVL6 Gene (Entity type)	0.012816561
(S)-N-(1-(4-(5-chloro-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidin-1-yl)propan-2-yl)naphthalene-2-carboxamide Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	ACAT2 Gene (Entity type)	0.013570332
(S)-N-(1-(4-(5-chloro-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidin-1-yl)propan-2-yl)naphthalene-2-carboxamide Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	TARBP1 Gene (Entity type)	-0.0065763113
(S)-N-(1-(4-(5-chloro-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidin-1-yl)propan-2-yl)naphthalene-2-carboxamide Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	SLC2A6 Gene (Entity type)	0.0080984235
(S)-N-(1-(4-(5-chloro-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidin-1-yl)propan-2-yl)naphthalene-2-carboxamide Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	CRIP1 Gene (Entity type)	-0.004881488
(S)-N-(1-(4-(5-chloro-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidin-1-yl)propan-2-yl)naphthalene-2-carboxamide Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	ALDOC Gene (Entity type)	0.010631223
(S)-N-(1-(4-(5-chloro-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidin-1-yl)propan-2-yl)naphthalene-2-carboxamide Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	KRT17 Gene (Entity type)	-0.0062557864

(S)-N-(1-(4-(5-chloro-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidin-1-yl)propan-2-yl)naphthalene-2-carboxamide
Compound (Entity type)
In similarity relationship with
Knowledge Graph Relation (Entity type)
Obatoclax
Compound (Entity type)
0.5574653744697571

(S)-N-(1-(4-(5-chloro-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidin-1-yl)propan-2-yl)naphthalene-2-carboxamide
Compound (Entity type)
In similarity relationship with
Knowledge Graph Relation (Entity type)
Thioridazine
Compound (Entity type)
0.5726276636123657

(S)-N-(1-(4-(5-chloro-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidin-1-yl)propan-2-yl)naphthalene-2-carboxamide
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
CLTB
Gene (Entity type)
-0.0049986923

(S)-N-(1-(4-(5-chloro-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidin-1-yl)propan-2-yl)naphthalene-2-carboxamide
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
ELOVL6
Gene (Entity type)
0.012816561

(S)-N-(1-(4-(5-chloro-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidin-1-yl)propan-2-yl)naphthalene-2-carboxamide
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
ACAT2
Gene (Entity type)
0.013570332

(S)-N-(1-(4-(5-chloro-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidin-1-yl)propan-2-yl)naphthalene-2-carboxamide
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
TARBP1
Gene (Entity type)
-0.0065763113

(S)-N-(1-(4-(5-chloro-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidin-1-yl)propan-2-yl)naphthalene-2-carboxamide
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
SLC2A6
Gene (Entity type)
0.0080984235

(S)-N-(1-(4-(5-chloro-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidin-1-yl)propan-2-yl)naphthalene-2-carboxamide
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
CRIP1
Gene (Entity type)
-0.004881488

(S)-N-(1-(4-(5-chloro-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidin-1-yl)propan-2-yl)naphthalene-2-carboxamide
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
ALDOC
Gene (Entity type)
0.010631223

(S)-N-(1-(4-(5-chloro-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidin-1-yl)propan-2-yl)naphthalene-2-carboxamide
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
KRT17
Gene (Entity type)
-0.0062557864

DISPLAY PER PAGE

Knowledge Graph Assertions

	Source	Relation	Target	Evidence
Loading results...

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.